| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/12/2009 | US20090069553 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 03/12/2009 | US20090069548 Immobilized Proteins and Methods and Uses Thereof |
| 03/12/2009 | US20090069535 Ligand (ACT-4-L) to a Receptor on the Surface of Activated CD4+ T-Cells |
| 03/12/2009 | US20090069274 Interferon-like protein zcyto21 |
| 03/12/2009 | US20090069258 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 03/12/2009 | US20090069241 Compositions and Methods for Use of Pigment Epithelial Derived Factor (PEDF) Peptide Fragments |
| 03/12/2009 | US20090069238 Activatable clostridial toxins |
| 03/12/2009 | US20090069236 PROCESS FOR THE PREPARATION OF HYPOALLERGENIC MAJOR BIRCH POLLEN ALLERGEN rBet v 1 |
| 03/12/2009 | US20090069232 Glycosylation of molecules |
| 03/12/2009 | US20090069229 Plant-made west nile virus (wnv) vaccines, vectors and plant codon optimized sequences |
| 03/12/2009 | US20090068745 Compositions and methods for performing reverse gene therapy |
| 03/12/2009 | US20090068737 Methods of inhibiting interleukin-17 receptor |
| 03/12/2009 | US20090068717 In vivo incorporation of unnatural amino acids |
| 03/12/2009 | US20090068706 Production of Highly Isotopically Labelled, Secondary, Microbial Metabolic Products, and Corresponding Metabolic Products |
| 03/12/2009 | US20090068705 Use of Copper Glutamate in Cell Culture for Production of Polypeptides |
| 03/12/2009 | US20090068703 Protein expression systems |
| 03/12/2009 | US20090068702 Method for producing a mucin-type glycoprotein |
| 03/12/2009 | US20090068695 Detecting activity of a Silent information regulator 2 by combining the composition with adenosine 5'-diphosphate and an acetylated Sir2 peptide substrate to deacetylate the peptide, and identifying 2'/3'-O-acetyl-ADP-ribose in the mixture to determine the presence of Sir2 activity |
| 03/12/2009 | US20090068679 Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, and production and use thereof |
| 03/12/2009 | US20090068636 Viral protein |
| 03/12/2009 | US20090068229 Modified surface antigen |
| 03/12/2009 | US20090068226 Bacterial superantigen vaccines |
| 03/12/2009 | US20090068221 Virus-like particles as vaccines for paramyxovirus |
| 03/12/2009 | US20090068213 Immunogenic composition for early detection of dengue virus |
| 03/12/2009 | US20090068205 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1 |
| 03/12/2009 | US20090068202 Humanized Anti-CD79B Antibodies and Immunoconjugates and Methods of Use |
| 03/12/2009 | US20090068201 Methods of treatment using antibodies to neutrokine-alpha |
| 03/12/2009 | US20090068198 Antibody and Uses Thereof |
| 03/12/2009 | US20090068191 Human Monoclonal Antibody Specific for Lipopolysaccharides (LPS) of the Pseudomonas Aeruginosa IATS 011 Serotype |
| 03/12/2009 | US20090068188 C-C chemokine receptor 3 proteins |
| 03/12/2009 | US20090068187 Novel 14275, 54420, 8797, 27439, 68730, 69112 and 52908 molecules and uses therefor |
| 03/12/2009 | US20090068185 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/12/2009 | US20090068178 Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin |
| 03/12/2009 | US20090068175 Optimized FC Variants and Methods for Their Generation |
| 03/12/2009 | US20090068173 Isolated from the saliva of Rhipicephalus sanguineus; antiinflammatory and immunomodulatory compounds; antagonists of CCL5 and CCL11 |
| 03/12/2009 | US20090068121 Lantibiotics and uses thereof |
| 03/12/2009 | US20090068110 Antibodies to insulin-like growth factor receptor |
| 03/12/2009 | US20090068109 Anti-mcp-1 antibodies, compositions, methods and uses |
| 03/12/2009 | DE102008035149A1 Separation method Separation method |
| 03/12/2009 | CA2711425A1 Antimicrobial activity of bacteriocin-producing lactic acid bacteria |
| 03/12/2009 | CA2698343A1 High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
| 03/12/2009 | CA2697612A1 Anti-igf-1r antibodies and uses thereof |
| 03/12/2009 | CA2696210A1 Compositions and methods comprising binding proteins for adalimumab |
| 03/11/2009 | EP2034024A1 Exo-endo cellulase fusion protein |
| 03/11/2009 | EP2034023A1 C-C CKR-5 ,CC-Chemikines receptor, derivatives thereof and their uses |
| 03/11/2009 | EP2033972A1 Screening method for candidate drugs |
| 03/11/2009 | EP2033970A2 WNT-1 inducible genes |
| 03/11/2009 | EP2033662A1 Transglutaminase mediated conjugation of peptides |
| 03/11/2009 | EP2033659A2 Inhibitors of complement activation |
| 03/11/2009 | EP2032162A2 Herv-k antigens, antibodies, and methods |
| 03/11/2009 | EP1885868A4 Production of enzymes |
| 03/11/2009 | EP1819830A4 Methods for antibody engineering |
| 03/11/2009 | EP1379550B1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 03/11/2009 | EP1325127B1 Method for the production of vitamin k-dependent proteins |
| 03/11/2009 | EP1305409B1 Renal regulatory elements and methods of use thereof |
| 03/11/2009 | EP1268799B1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 03/11/2009 | EP1071763B1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 03/11/2009 | EP0741784B1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
| 03/11/2009 | CN101384902A Compositions and methods related to controlled gene expression using viral vectors |
| 03/11/2009 | CN101384711A Non-natural amino acid polypeptides having modulated immunogenicity |
| 03/11/2009 | CN101384623A Process for the production of preformed conjugates of albumin and a therapeutic agent |
| 03/11/2009 | CN101381759A Preparation method of buckwheat protein biological activity peptides |
| 03/11/2009 | CN101381758A Method for extracting fibroin peptide from mulberry silk |
| 03/11/2009 | CN101381757A Solid fermentation preparation method of antibacterial peptide and application |
| 03/11/2009 | CN101381727A Construction of human insulinogen C peptide high-yield strains |
| 03/11/2009 | CN101381411A Sipunculid collagen protein and preparation method thereof |
| 03/11/2009 | CN101381401A Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 03/11/2009 | CN100467611C Purification of polypeptides |
| 03/11/2009 | CN100467603C DNA sequences coding for the human proteins TX and TY related to the interleukin-IBeta converting enzyme |
| 03/11/2009 | CN100467596C Insulin-expressing human islet cell lines capable of reversibly proliferating and use thereof |
| 03/11/2009 | CN100467488C Il-7 fusion proteins |
| 03/10/2009 | US7501553 Non-human transgenic mammal comprising a modified MSP-1 nucleic acid |
| 03/10/2009 | US7501552 Transgenic non-human animals for producing chimeric antibodies |
| 03/10/2009 | US7501502 Viral vectors with nucleotide sequence operably linked to cytomegalo virus promoter for expression; host cells, genetic engineering; 85P1B3 gene or fragment or its encoded protein which can be used to elicit an immune response; diagnosis |
| 03/10/2009 | US7501498 Moncolonal antibody for use in diagnosis and treatment of cell proliferative disorders; immunotherapy; tissue engineering |
| 03/10/2009 | US7501497 Comprising transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptor moiety and an immunoglobulin moiety comprising a heavy chain constant region of an immunoglobulin; interfere with binding of a tumor necrosis factor receptor with its ligand; antitumor agents |
| 03/10/2009 | US7501495 Method for improving recovery yield in protein purification with gel filtration chromatography |
| 03/10/2009 | US7501494 Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection |
| 03/10/2009 | US7501491 recombinant viral genome containing a deletion in the glycoprotein genes; polypeptide is derived from infectious bronchitis virus, Newcastle disease virus, infectious bursal disease virus, and Marek's disease virus; vaccines |
| 03/10/2009 | US7501488 Proteorhodopsin mutants with improved optical characteristics |
| 03/10/2009 | US7501487 Polypeptides that modulate transcription; DNA encoding receptors, expression vectors, cells transformed with such expression vectors; hormone-like proteins; differ from known retinoic acid receptors in protein primary sequence and in responsiveness to various retinoids |
| 03/10/2009 | US7501484 Methods and DNA constructs for high yield production of polypeptides |
| 03/10/2009 | US7501392 Method of treatment of viral hepatitis C with interferon alpha 5 |
| 03/10/2009 | US7501273 Peptidylarginine deiminase 6 |
| 03/10/2009 | US7501271 Anthocyanin 5-O-glucosyltransferases, an enzyme that transfers a glycoside to the 5 position of a flavonoid, isolated from Perilla fruescens, Verbena hybrida, Torenia hybrida, and Petunia hybrida; artificially coloring plants and flowers |
| 03/10/2009 | US7501270 Oxygen-resistant hydrogenases and methods for designing and making same |
| 03/10/2009 | US7501267 Gene sequence of L-rhamnose isomerase having new catalytic function and use thereof |
| 03/10/2009 | US7501265 Method for producing and cleaving a fusion proteins with an n-terminal chymosin pro-peptide |
| 03/10/2009 | US7501263 Nucleic acids encoding mammalian T-type calcium channels |
| 03/10/2009 | US7501262 Recombinant DNA, gene expression vectors, and transformants capable of expressing a gene without inducing gene expression with an inducer; genetic engineering |
| 03/10/2009 | US7501261 Contacting target cellular nucleic acid in test cell with reagent that detects tumor suppressor lung cancer 1 (TSLC1) and detecting a reduction in test cell; detecting an increase or decrease in methylation; marker for progression to invasive cervical cancer and metastatic potential of cervical lesions |
| 03/10/2009 | US7501249 Human cytoplasmic polyadenylation element binding protein and uses thereof |
| 03/10/2009 | US7501246 Gene for coding thermostable L-arabinose isomerase and method for producing the same |
| 03/10/2009 | US7501234 Stress proteins and uses therefor |
| 03/10/2009 | US7501124 Administering allogenic or xenogeneric cell; complexing with antigen |
| 03/10/2009 | CA2301046C 13c, 15n, 2h labeled proteins for nmr structure determinations and their preparation |
| 03/10/2009 | CA2270408C Monoclonal antibodies against the ypydvpdya epitope, process for producing the same and their use |
| 03/10/2009 | CA2252896C Inactivation resistant factor viii |
| 03/10/2009 | CA2145278C Target binding polypeptide |
| 03/07/2009 | CA2598966A1 Anti-chikungunya monoclonal antibodies and uses thereof |